Metabolic syndrome is a cluster of conditions, increased blood pressure, a high blood sugar level, excess body fat around the waist and abnormal cholesterol levels that occur together, increasing your risk of heart disease, stroke and diabetes.
It has been established that patients diagnosed with metabolic syndrome (MS) have significantly greater incidence of developing type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Indeed, diabetes is a nationwide epidemic in the United States affecting nearly 26 million Americans, with 90-95% of these cases being T2DM. The monetary costs for diabetes alone accounts for an estimated 245 billion dollars in the United States annually. CVD is the primary cause of death in people with T2DM and ranks number one in fatalities worldwide. Similar to increased incidences of individuals with T2DM, diagnosis of people with MS is steadily rising.
The open access journals are peer reviewed scholarly journals of Metabolic Syndrome. The top open access journals are freely available on the public internet domain, allowing any end users to read, download, copy, distribute, prink, search or link to the full texts of the articles. These provide high quality, meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These journals are indexed with all their citations noted. The top open access journals are indexed in SCOPUS, COPERNICUS, CAS, EBSCO and ISI.
Last date updated on April, 2021